This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

AstraZeneca signs five-year licensing deal for RNA therapeutics


AstraZeneca has signed a five-year licensing deal with Moderna Therapeutics, a US biotechnology company specialising in drugs using RNA therapeutics.

AstraZeneca, Moderna Therapeutics, RNA, licensing deal, initial payment


Payment types accepted